Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The understanding of ARVC pathophysiology remains incomplete. Several clues indicate that disease progression is mediated through inflammation. The present study aim to document the feasibility of detecting the potential presence of intracardiac local inflammatory components in patients with ARVC.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:
• For cases:
‣ Arrhythmogenic right ventricular dysplasia diagnosed (according to 2010 Task Force Criteria)
⁃ Admitted for right ventricle electrophysiologic mapping
• For controls \* Admitted for ablation procedures (accessory pathway, atrial flutter) on otherwise healthy hearts.
Locations
Other Locations
France
Toulouse University Hospital Center
RECRUITING
Toulouse
Contact Information
Primary
Philippe MAURY, MD
maury.p@chu-toulouse.fr
5 61 32 34 70
Backup
Maxime BENEYTO
beneyto.m@chu-toulouse.fr
Time Frame
Start Date: 2022-02-01
Estimated Completion Date: 2026-02
Participants
Target number of participants: 80
Treatments
Experimental: Patients
Carrier of a definite diagnosis of arrhythmogenic dysplasia of the right ventricle in line with the criteria of the Task Force 2010 (see Appendices), admitted for an electrical mapping of the right ventricle
Experimental: Control case
Without heart disease, admitted for a Kent bundle ablation or endocavity procedure / Wolff-Parkinson-White syndrome or common flutter (in subjects in whom the same irrigated material will be used and for whom echocardiography will have excluded associated heart disease).
Authors
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Toulouse